164 related articles for article (PubMed ID: 38337419)
21. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
22. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
[No Abstract] [Full Text] [Related]
23. Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis.
Li M; Zhao X; Liu B; Zhao Y; Li X; Ma Z; Yang Q
Front Immunol; 2023; 14():1209282. PubMed ID: 37691917
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis.
Temmoku J; Sato S; Fujita Y; Asano T; Suzuki E; Kanno T; Furuya MY; Matsuoka N; Kobayashi H; Watanabe H; Koga T; Shimizu T; Kawakami A; Migita K
Medicine (Baltimore); 2019 May; 98(20):e15578. PubMed ID: 31096460
[TBL] [Abstract][Full Text] [Related]
25. MDA5 expression is associated with TGF-β-induced fibrosis: potential mechanism of interstitial lung disease in anti-MDA5 dermatomyositis.
Shen N; Zhou X; Jin X; Lu C; Hu X; Zhang Y; Jiang Y; Xu Q; Xu X; Liu M; Lu L; Han Y
Rheumatology (Oxford); 2022 Dec; 62(1):373-383. PubMed ID: 35412608
[TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis.
Wang LM; Yang QH; Zhang L; Liu SY; Zhang PP; Zhang X; Liu XJ; Han LS; Li TF
Rheumatology (Oxford); 2022 Aug; 61(9):3704-3710. PubMed ID: 34940809
[TBL] [Abstract][Full Text] [Related]
27. Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis.
Horai Y; Koga T; Fujikawa K; Takatani A; Nishino A; Nakashima Y; Suzuki T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Ida H; Kakugawa T; Sakamoto N; Ishimatsu Y; Mukae H; Hamaguchi Y; Fujimoto M; Kuwana M; Origuchi T; Kohno S; Kawakami A
Mod Rheumatol; 2015 Jan; 25(1):85-9. PubMed ID: 24716595
[TBL] [Abstract][Full Text] [Related]
28. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
[TBL] [Abstract][Full Text] [Related]
29. Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.
Hoa S; Troyanov Y; Fritzler MJ; Targoff IN; Chartrand S; Mansour AM; Rich E; Boudabbouz H; Bourré-Tessier J; Albert M; Goulet JR; Landry M; Senécal JL
Scand J Rheumatol; 2018 May; 47(3):210-224. PubMed ID: 29065773
[TBL] [Abstract][Full Text] [Related]
30. Initial predictors for short-term prognosis in anti-melanoma differentiation-associated protein-5 positive patients.
Yang Q; Li T; Zhang X; Lyu K; Wu S; Chen Y; Liu S; Yu Z
Orphanet J Rare Dis; 2021 Jan; 16(1):58. PubMed ID: 33516242
[TBL] [Abstract][Full Text] [Related]
31. Plasma exchange for anti-MDA5 antibody-positive dermatomyositis-associated rapidly progressive interstitial lung disease: A case report and literature review.
Lu C; Xu C; Zhu X; Han Y
J Int Med Res; 2023 Sep; 51(9):3000605231198742. PubMed ID: 37728627
[TBL] [Abstract][Full Text] [Related]
32. Effect of high-dose intravenous methylprednisolone pulse (IVMP) therapy in the survival of patients with anti-melanoma differentiation-associated gene 5-related rapidly progressive interstitial lung disease: a retrospective analysis.
Fan L; Li Y; Lyu W; Xu Q; Gao Y; Qiu X; Cai H; Dai J
Clin Rheumatol; 2024 Mar; 43(3):1135-1143. PubMed ID: 38289569
[TBL] [Abstract][Full Text] [Related]
33. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.
Chen Z; Cao M; Plana MN; Liang J; Cai H; Kuwana M; Sun L
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1316-24. PubMed ID: 23908005
[TBL] [Abstract][Full Text] [Related]
34. Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease.
Chen X; Jiang W; Jin Q; Peng Q; Zhang L; Lin S; Lu X; Liu M; Wang Y; Song A; Feng R; Wang G
RMD Open; 2023 May; 9(2):. PubMed ID: 37258042
[TBL] [Abstract][Full Text] [Related]
35. Fever, Cutaneous Ulcers, and Arthritis Define the MDA5 Phenotype in Indian Patients with Idiopathic Inflammatory Myositis.
Devarasetti P; Mohammad I; Desai A; Rajasekhar L
Mediterr J Rheumatol; 2022 Dec; 33(4):413-420. PubMed ID: 37034362
[TBL] [Abstract][Full Text] [Related]
36. Fatal and extensive multiorgan hemorrhages in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: An autopsy case report.
Watanabe T; Takizawa N; Nagasaka T; Nakamura Y; Ikai H; Yamamoto M; Murai Y; Takasugi K; Yokoyama-Kokuryo W; Fujita Y
Medicine (Baltimore); 2020 Jan; 99(3):e18600. PubMed ID: 32011440
[TBL] [Abstract][Full Text] [Related]
37. Increased serum levels of sCD40L were associated with rapidly progressive interstitial lung disease in idiopathic inflammatory myopathies.
Lyu W; Zhou W; Xu Q; Liu X; Liu Y; Zhang Y; Qiu Y; Huang M; Cao M; Xiao Y; Cai H; Dai J
Clin Exp Rheumatol; 2023 Mar; 41(2):267-274. PubMed ID: 36826792
[TBL] [Abstract][Full Text] [Related]
38. Associations between anti-melanoma differentiation-associated gene 5 antibody and demographics, clinical characteristics and laboratory results of patients with dermatomyositis: A systematic meta-analysis.
Li J; Liu Y; Li Y; Li F; Wang K; Pan W; Meng D
J Dermatol; 2018 Jan; 45(1):46-52. PubMed ID: 28983955
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease.
Matsushita T; Kobayashi T; Kano M; Hamaguchi Y; Takehara K
J Dermatol; 2019 Dec; 46(12):1190-1196. PubMed ID: 31631384
[TBL] [Abstract][Full Text] [Related]
40. Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.
Wu W; Guo L; Fu Y; Wang K; Zhang D; Xu W; Chen Z; Ye S
Clin Rev Allergy Immunol; 2021 Apr; 60(2):293-304. PubMed ID: 33405101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
